Table 1

Baseline characteristics of SEED participants stratified by ethnicity and incident CKD status

VariableChineseMalaysIndians
No CKD
(n=2097)
CKD
(n=137)
P value*No CKD
(n=1326)
CKD
(n=148)
P value*No CKD
(n=1764)
CKD
(n=108)
P value*
Age, year56.7 (8.2)67.1 (8)<0.00154.3 (9.1)63.2 (8)<0.00154.8 (8.2)65.7 (8)<0.001
Gender, N (%)<0.0010.1180.692
 Female1097 (95.8)48 (4.2)735 (91.1)72 (8.9)875 (94.5)51 (5.5)
 Male1000 (91.8)89 (8.2)591 (88.6)76 (11.4)889 (94)57 (6)
Education†, N (%)<0.001<0.001<0.001
 Primary/below966 (91.5)90 (8.5)806 (87.4)116 (12.6)861 (92.3)72 (7.7)
 Secondary/above1131 (96)47 (4)520 (94.2)32 (5.8)903 (96.2)36 (3.8)
Diabetes mellitus, N (%)<0.001<0.001<0.001
 No1820 (95.8)79 (4.2)1028 (93.6)70 (6.4)1209 (97.1)36 (2.9)
 Yes277 (82.7)58 (17.3)298 (79.3)78 (20.7)555 (88.5)72 (11.5)
Hypertension, N (%)<0.001<0.001<0.001
 No1018 (98.3)18 (1.7)572 (98.3)10 (1.7)862 (98.4)14 (1.6)
 Yes1079 (90.1)119 (9.9)754 (84.5)138 (15.5)902 (90.6)94 (9.4)
Current smoking, N (%)0.6940.5850.474
 No1828 (93.9)118 (6.1)1064 (89.7)122 (10.3)1516 (94)96 (6)
 Yes269 (93.4)19 (6.6)262 (91)26 (9)248 (95.4)12 (4.6)
Dyslipidemia, N (%)<0.0010.020<0.001
 No1206 (95.9)52 (4.1)843 (91.4)79 (8.6)1005 (96.3)39 (3.7)
 Yes891 (91.3)85 (8.7)483 (87.5)69 (12.5)759 (91.7)69 (8.3)
Cardiovascular disease, N (%)<0.0010.002<0.001
 No2008 (94.6)115 (5.4)1245 (90.7)128 (9.3)1594 (95.2)81 (4.8)
 Yes89 (80.2)22 (19.8)81 (80.2)20 (19.8)170 (86.3)27 (13.7)
Obesity, N (%)0.0030.0641.000
 No1456 (94.9)78 (5.1)546 (91.8)49 (8.2)760 (94.3)46 (5.7)
 Yes641 (91.6)59 (8.4)780 (88.7)99 (11.3)1004 (94.2)62 (5.8)
Body mass index, kg/m223.7 (3.6)24.7 (3.2)<0.00126.4 (4.9)27.6 (4.5)0.00126.2 (4.4)26.3 (4.3)0.955
Blood glucose, mmol/L6.1 (2.2)7.8 (3.9)<0.0016.2 (3)8.7 (5.5)<0.0016.8 (3.1)7.8 (3.3)<0.001
Systolic blood pressure, mm Hg133.5 (18.2)145.6 (17.8)<0.001140.2 (21)158.5 (22.3)<0.001132.4 (18.6)147.8 (19.6)<0.001
Diastolic blood pressure, mm Hg77.6 (9.8)79 (9.4)0.11278.9 (10.5)81.6 (12.8)0.02978.1 (10.1)78.2 (9.9)0.913
Pulse pressure, mm Hg55.9 (14.3)66.6 (15.7)<0.00161.3 (16)76.9 (16.7)<0.00154.4 (14.3)69.6 (16.5)<0.001
Antihypertensive medication use‡, N (%)<0.001<0.001<0.001
 No513 (94.3)31 (5.7)482 (87.8)67 (12.2)375 (95.4)18 (4.6)
 Yes566 (86.5)88 (13.5)272 (79.3)71 (20.7)527 (87.4)76 (12.6)
Total cholesterol, mmol/L5.5 (1)5.2 (1.1)<0.0015.6 (1.1)5.5 (1.2)0.7345.3 (1.1)4.9 (1.1)0.005
HDL cholesterol, mmol/L1.3 (0.4)1.2 (0.4)0.0021.4 (0.3)1.3 (0.3)<0.0011.1 (0.3)1.1 (0.3)0.512
Baseline eGFR, mL/min/1.73 m294.1 (12.7)73.4 (10.3)<0.00183.9 (14)74.4 (11.8)<0.00192.6 (12.8)73.7 (10.3)<0.001
Alcohol consumption, N (%)0.2150.5070.192
 No1850 (93.6)126 (6.4)1301 (89.8)147 (10.2)1531 (94.5)89 (5.5)
 Yes247 (95.7)11 (4.3)25 (96.2)1 (3.8)233 (92.5)19 (7.5)
  • Data presented are counts (row percentage) or means (SD).

  • *P value represents difference in characteristics by incident CKD status based on Mann-Whitney test or Fisher’s exact test as appropriate for the variable.

  • †Highest education level attained was categorized as no formal education or completed primary school education versus completed at least secondary school with Singapore Cambridge General Certificate of Education Ordinary level or equivalent.

  • ‡Among those with self-reported hypertension.

  • CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; SEED, Singapore Epidemiology of Eye Disease.